Impel NeuroPharma, Inc. (IMPL) stock falls down in aftermarket – Here’s why?

Impel NeuroPharma, Inc. (IMPL) saw a decrease of 6.69% in aftermarket. However, the last trading session concluded at $8.82 with a decrease of 0.79%. Third Quarter 2021 Financial results – What’s going on? IMPL reported the third quarter of 2021 results on 15th November 2021. The company recorded $0.1 million in product revenue, net of […]

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.